Federal Register / Vol. 89, No. 216 / Thursday, November 7, 2024 / Notices 88281 

Estimated Time per Response: 0.017 

hours–52 hours. 

Obligation To Respond: Required to 

obtain or retain benefits. The statutory 

authority for this collection of 

information is contained in Sections 

154(i), 307, 308, 309 and 319 of the 

Communications Act of 1934, as 

amended. 

Total Annual Burden: 172,087 hours. 

Total Annual Cost: $1,851,000. 

Needs and Uses: On November 29, 

1999, the Community Broadcasters 

Protection Act of 1999 (CBPA), Public 

Law 106–113, 113 Stat. appendix I at 

pp. 1501A–594–1501A–598 (1999), 

codified at 47 U.S.C. 336(f), was 

enacted. That legislation provided that a 

low power television (LPTV) licensee 

should be permitted to convert the 

secondary status of its station to the new 

Class A status, provided it can satisfy 

certain statutorily-established criteria by 

January 28, 2000. The CBPA directs that 

Class A licensees be subject to the same 

license terms and renewal standards as 

full-power television licenses and that 

Class A licensees be accorded primary 

status as television broadcasters as long 

as they continue to meet the 

requirements set forth in the statute for 

a qualifying low power station. 

For those stations that met the 

certification deadline, the CBPA sets out 

certain certification procedures, 

prescribes the criteria to maintain a 

Class A license, and outlines the 

interference protection Class A stations 

must provide to analog, digital, LPTV 

and TV translator stations. 

The CBPA directs that Class A 

stations must comply with the operating 

requirements for full-service television 

broadcast stations in order to maintain 

Class A status. Therefore, beginning on 

the date of its application for a Class A 

license and thereafter, a station must be 

‘‘in compliance’’ with the Commission’s 

operating rules for full-service television 

stations, contained in 47 CFR part 73. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary, Office of the Secretary. 

[FR Doc. 2024–25895 Filed 11–6–24; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meetings 

TIME AND DATE: Wednesday, November 

13, 2024, at 10:00 a.m. and its 

continuation at the conclusion of the 

open meeting on November 14, 2024. 

PLACE: 1050 First Street NE, 

Washington, DC, and virtual (This 

meeting will be a hybrid meeting.) 

STATUS: This meeting will be closed to 

the public. 

MATTERS TO BE CONSIDERED: 

Compliance matters pursuant to 52 

U.S.C. 30109. 

Matters relating to internal personnel 

decisions, or internal rules and 

practices. 

Information the premature disclosure 

of which would be likely to have a 

considerable adverse effect on the 

implementation of a proposed 

Commission action. 

Matters concerning participation in 

civil actions or proceedings or 

arbitration. 

CONTACT PERSON FOR MORE INFORMATION: 

Judith Ingram, Press Officer, Telephone: 

(202) 694–1220. 

(Authority: Government in the Sunshine Act, 

5 U.S.C. 552b) 

Vicktoria J. Allen, 

Deputy Secretary of the Commission. 

[FR Doc. 2024–25999 Filed 11–5–24; 4:15 pm] 

BILLING CODE 6715–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee; Correction 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice; correction. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces an 

amendment to the following meeting of 

the Healthcare Infection Control 

Practices Advisory Committee 

(HICPAC). The meeting is open to the 

public. 

FOR FURTHER INFORMATION CONTACT: 

Sydnee Byrd, M.P.A., Program Analyst, 

Division of Healthcare Quality 

Promotion, National Center for 

Emerging and Zoonotic Infectious 

Diseases, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H16–3, Atlanta, Georgia 

30329–4027. Telephone: (404) 718– 

8039; Email: HICPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Correction 

Notice is hereby given of a change in 

the meeting of the Healthcare Infection 

Control Practices Advisory Committee; 

November 14, 2024, from 9 a.m. to 5 

p.m., EST, and November 15, 2024, from 

9 a.m. to 12 p.m., EST, in the original 

Federal Register notice. 

Notice of the virtual meeting was 

published in the Federal Register on 

October 17, 2024, 89 FR 83688. 

The meeting notice is being amended 

to update the dates section; addresses 

section; and supplementary information 

section, including the addition of 

instructions for providing written public 

comment. These sections should read as 

follows: 

DATES: The meeting will be held on 

November 14, 2024, from 8 a.m. to 5:45 

p.m., EST, and November 15, 2024, from 

8 a.m. to 12:30 p.m., EST. 

ADDRESSES: The meeting will be 

webcast live via the World Wide Web. 

The webcast link can be found on the 

HICPAC website at https://

www.cdc.gov/hicpac/php/upcomingmeeting/index.html. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Healthcare Infection 

Control Practices Advisory Committee 

(HICPAC) is charged with providing 

advice and guidance to the Director, 

Division of Healthcare Quality 

Promotion; the Director, National Center 

for Emerging and Zoonotic Infectious 

Diseases; the Director, Centers for 

Disease Control and Prevention (CDC); 

and the Secretary, Department of Health 

and Human Services, regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters to be Considered: The agenda 

will include the following updates: the 

Division of Healthcare Quality 

Promotion; the Isolation Precautions 

Guideline Workgroup; and the 

Healthcare Personnel Guideline 

Workgroup. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. All 

persons interested in making an oral 

public comment at the November 14–15, 

2024, HICPAC meeting must submit a 

request between October 15, 2024, and 

October 25, 2024, at https://

www.cdc.gov/hicpac/php/upcomingVerDate Sep<11>2014 18:15 Nov 06, 2024 Jkt 265001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\07NON1.SGM 07NON1

lotter on DSK11XQN23PROD with NOTICES1
88282 Federal Register / Vol. 89, No. 216 / Thursday, November 7, 2024 / Notices 

meeting/index.html no later than 5 p.m., 

EDT, on October 25, 2024, according to 

the instructions provided. If the number 

of persons requesting to speak is greater 

than can be reasonably accommodated 

during the scheduled time, CDC will 

conduct a random draw to determine 

the speakers for the scheduled public 

comment session. CDC staff will notify 

individuals regarding their request to 

speak by email by November 1, 2024. 

Written Public Comment: Written 

comments should be submitted by email 

to HICPAC@cdc.gov. The deadline for 

receipt of written public comments is 

November 22, 2024. All submissions 

must contain the submitter’s name, 

address, and organizational affiliation, 

as well as the topic being addressed. 

Written comments should not exceed 

one single-spaced typed page in length, 

not including attachments. All written 

comments will be shared with the 

Committee. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–25906 Filed 11–6–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–9150–N] 

Medicare and Medicaid Programs; 

Quarterly Listing of Program 

Issuances—July through September 

2024 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Notice 

SUMMARY: This quarterly notice lists 

CMS manual instructions, substantive 

and interpretive regulations, and other 

Federal Register notices that were 

published in the 3-month period, 

relating to the Medicare and Medicaid 

programs and other programs 

administered by CMS. 

FOR FURTHER INFORMATION CONTACT: It is 

possible that an interested party may 

need specific information and not be 

able to determine from the listed 

information whether the issuance or 

regulation would fulfill that need. 

Consequently, we are providing contact 

persons to answer general questions 

concerning each of the addenda 

published in this notice. 

Addenda Contact Phone number 

I—CMS Manual Instructions ..................................................................................................... Ismael Torres ......................... (410) 786–1864 

II—Regulation Documents Published in the FEDERAL REGISTER ............................................. Terri Plumb ............................. (410) 786–4481 

III—CMS Rulings ...................................................................................................................... Tiffany Lafferty ........................ (410) 786–7548 

IV—Medicare National Coverage Determinations .................................................................... Wanda Belle, MPA ................. (410) 786–7491 

V—FDA-Approved Category B IDEs ........................................................................................ John Manlove ......................... (410) 786–6877 

VI—Collections of Information .................................................................................................. William Parham ...................... (410) 786–4669 

VII—Medicare–Approved Carotid Stent Facilities .................................................................... Sarah Fulton, MHS ................. (410) 786–2749 

VIII—American College of Cardiology-National Cardiovascular Data Registry Sites .............. Sarah Fulton, MHS ................. (410) 786–2749 

IX—Medicare’s Active Coverage-Related Guidance Documents ............................................ Lori Ashby, MA ....................... (410) 786–6322 

X—One-time Notices Regarding National Coverage Provisions ............................................. JoAnna Baldwin, MS .............. (410) 786–7205 

XI—National Oncologic Positron Emission Tomography Registry Sites ................................. David Dolan, MBA .................. (410) 786–3365 

XII—Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities .............. David Dolan, MBA .................. (410) 786–3365 

XIII—Medicare-Approved Lung Volume Reduction Surgery Facilities ..................................... Sarah Fulton, MHS ................. (410) 786–2749 

XIV—Medicare-Approved Bariatric Surgery Facilities .............................................................. Sarah Fulton, MHS ................. (410) 786–2749 

XV—Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials ...................... David Dolan, MBA .................. (410) 786–3365 

All Other Information ................................................................................................................. Annette Brewer ....................... (410) 786–6580 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Centers for Medicare & Medicaid 

Services (CMS) is responsible for 

administering the Medicare and 

Medicaid programs and coordination 

and oversight of private health 

insurance. Administration and oversight 

of these programs involves the 

following: (1) furnishing information to 

Medicare and Medicaid beneficiaries, 

health care providers, and the public; 

and (2) maintaining effective 

communications with CMS regional 

offices, state governments, state 

Medicaid agencies, state survey 

agencies, various providers of health 

care, all Medicare contractors that 

process claims and pay bills, National 

Association of Insurance Commissioners 

(NAIC), health insurers, and other 

stakeholders. To implement the various 

statutes on which the programs are 

based, we issue regulations under the 

authority granted to the Secretary of the 

Department of Health and Human 

Services under sections 1102, 1871, 

1902, and related provisions of the 

Social Security Act (the Act) and Public 

Health Service Act. We also issue 

various manuals, memoranda, and 

statements necessary to administer and 

oversee the programs efficiently. 

Section 1871(c) of the Act requires 

that we publish a list of all Medicare 

manual instructions, interpretive rules, 

statements of policy, and guidelines of 

general applicability not issued as 

regulations at least every 3 months in 

the Federal Register. 

II. Format for the Quarterly Issuance 

Notices 

This quarterly notice provides only 

the specific updates that have occurred 

in the 3-month period along with a 

hyperlink to the full listing that is 

available on the CMS website or the 

appropriate data registries that are used 

as our resources. This is the most 

current up-to-date information and will 

be available earlier than we publish our 

quarterly notice. We believe the website 

list provides more timely access for 

beneficiaries, providers, and suppliers. 

We also believe the website offers a 


lotter on DSK11XQN23PROD with NOTICES1